These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8343002

  • 1. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients.
    Groeger JS, Lucas AB, Coit D, LaQuaglia M, Brown AE, Turnbull A, Exelby P.
    Ann Surg; 1993 Aug; 218(2):206-10. PubMed ID: 8343002
    [Abstract] [Full Text] [Related]

  • 2. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial.
    Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB.
    Am J Med; 1988 Sep; 85(3):307-14. PubMed ID: 3046351
    [Abstract] [Full Text] [Related]

  • 3. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B.
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections.
    Hasaniya NW, Angelis M, Brown MR, Yu M.
    Chest; 1996 Apr; 109(4):1030-2. PubMed ID: 8635326
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group.
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [Abstract] [Full Text] [Related]

  • 6. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ, Zack JE, Thomas J, Borecki IB, Sona CS, Schallom ME, Venker M, Nemeth JL, Ward MR, Verjan L, Warren DK, Fraser VJ, Mazuski JE, Boyle WA, Buchman TG, Coopersmith CM.
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 10. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A.
    Clin Infect Dis; 2008 Nov 01; 47(9):1171-5. PubMed ID: 18808356
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of subcutaneous tunneling for prevention of bacterial colonization of femoral central venous catheters in critically ill children.
    Nahum E, Levy I, Katz J, Samra Z, Ashkenazi S, Ben-Ari J, Schonfeld T, Dagan O.
    Pediatr Infect Dis J; 2002 Nov 01; 21(11):1000-4. PubMed ID: 12442019
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of silver-coating central venous catheters in reducing bacterial colonization.
    Bach A, Eberhardt H, Frick A, Schmidt H, Böttiger BW, Martin E.
    Crit Care Med; 1999 Mar 01; 27(3):515-21. PubMed ID: 10199530
    [Abstract] [Full Text] [Related]

  • 13. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L, Lecuona M, Jiménez A, Raja L, Cabrera J, Gonzalez O, Diosdado S, Marca L, Mora ML.
    Am J Infect Control; 2016 Jan 01; 44(1):50-3. PubMed ID: 26412482
    [Abstract] [Full Text] [Related]

  • 14. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodey GP.
    Arch Intern Med; 1993 Aug 09; 153(15):1791-6. PubMed ID: 8392831
    [Abstract] [Full Text] [Related]

  • 15. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections.
    Dahlberg PJ, Agger WA, Singer JR, Yutuc WR, Newcomer KL, Schaper A, Rooney BL.
    Infect Control Hosp Epidemiol; 1995 Sep 09; 16(9):506-11. PubMed ID: 8537627
    [Abstract] [Full Text] [Related]

  • 16. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
    Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D.
    Ann Intern Med; 1993 Dec 15; 119(12):1168-74. PubMed ID: 8239247
    [Abstract] [Full Text] [Related]

  • 17. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L, Lecuona M, Jiménez A, Cabrera J, Santacreu R, Lorenzo L, Raja L, Mora ML.
    Am J Infect Control; 2016 Dec 01; 44(12):1526-1529. PubMed ID: 27378009
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.
    Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II.
    Ann Surg; 2005 Aug 01; 242(2):193-200. PubMed ID: 16041209
    [Abstract] [Full Text] [Related]

  • 19. Comparative Complication Rates of 854 Central Venous Access Devices for Home Parenteral Nutrition in Cancer Patients: A Prospective Study of Over 169,000 Catheter-Days.
    Cotogni P, Mussa B, Degiorgis C, De Francesco A, Pittiruti M.
    JPEN J Parenter Enteral Nutr; 2021 May 01; 45(4):768-776. PubMed ID: 32511768
    [Abstract] [Full Text] [Related]

  • 20. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter.
    Böswald M, Lugauer S, Regenfus A, Braun GG, Martus P, Geis C, Scharf J, Bechert T, Greil J, Guggenbichler JP.
    Infection; 1999 May 01; 27 Suppl 1():S56-60. PubMed ID: 10379447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.